Galectin Therapeutics | GALT - DEBITO

Prezzo Delle Azioni
3.03
Cambio Giornaliero
-0.08 -2.57%
Mensile
8.21%
Annuale
89.38%
Q1 Previsione
2.89




DEBITO Cambiamento Data
AbbVie USD 1000K 70.48B 2025-09
Bristol-Myers Squibb USD 51.04B 112M 2025-09
Galectin Therapeutics USD 71.74M 10.6M 2023-12
Gilead Sciences USD 24.94B 5M 2025-09
Immunic USD 0 0 2024-06
Incyte USD 40.41M 855K 2025-12
Merck USD 41.37B 5.97B 2025-09